4//SEC Filing
Omega Fund V GP Manager, Ltd. 4
Accession 0000899243-19-024045
CIK 0001728117other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 3:51 PM ET
Size
8.8 KB
Accession
0000899243-19-024045
Insider Transaction Report
Form 4
Omega Fund V, L.P.
10% Owner
Transactions
- Sale
Common Stock
2019-09-20$21.96/sh−183,607$4,032,561→ 6,553,416 total
Omega Fund V GP, L.P.
10% Owner
Transactions
- Sale
Common Stock
2019-09-20$21.96/sh−183,607$4,032,561→ 6,553,416 total
Omega Fund V GP Manager, Ltd.
10% Owner
Transactions
- Sale
Common Stock
2019-09-20$21.96/sh−183,607$4,032,561→ 6,553,416 total
Footnotes (3)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.50 to $22.19 per share, inclusive.
- [F2]The reported securities are held directly by Omega Fund V, L.P. ("Omega V"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. ("Omega V GP"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. ("Omega V GP Manager"), as the general partner of Omega V GP. Otello Stampacchia, Richard Lim, Anne-Mari Paster and Claudio Nessi (the "Omega Directors") are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Each of Omega V GP, Omega Fund V GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any.
- [F3]After completing the transactions reported above, none of the reporting persons, directly or indirectly, hold 10% or more of the issuer's outstanding Common Stock.
Documents
Issuer
Gossamer Bio, Inc.
CIK 0001728117
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001641348
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 3:51 PM ET
- Size
- 8.8 KB